The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1560 · Cited by 1,200
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Bierhaus, A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00233-2 · Cited by 555
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Schröder, S., Palinski, W., & Schmid‐Schönbein, G. W. (1991) · PubMed Central · Cited by 479
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Self-citationAdvanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
Yamagishi, S.-I., & Imaizumi, T. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054367300 · Cited by 452
Self-citationDE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
PEDF: a multifaceted neurotrophic factor
Tombran-Tink, J., & Barnstable, C. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1176 · Cited by 367
Central role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17115 · Cited by 367
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., ARCHER, D. B., & Vlassara, H. (1997) · Europe PMC (PubMed Central) · Cited by 324
Yamagishi, S.-I., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., & Makita, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202634200 · Cited by 310
Self-citationPigment epithelium‐derived factor (PEDF) is an endogenous antiinflammatory factor
Zhang, S. X., Wang, J. J., Gao, G., Shao, C., Mott, R., & Ma, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-4313fje · Cited by 299
Nomura, M., Yamagishi, S.-I., Harada, S.-I., Hayashi, Y., Yamashima, T., Yamashita, J., & Yamamoto, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28316 · Cited by 297
Self-citationAdvanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 294
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Stern, D., Du Yan, S., Fang Yan, S., & Marie Schmidt, A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00160-6 · Cited by 281
Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
Advanced Glycation End Products-driven Angiogenesis in Vitro
Yamagishi, S.-I., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., Ooka, H., Satozawa, N., Kawakami, T., Nomura, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8723 · Cited by 276
Self-citationPossible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00214.x · Cited by 267
The role of podocytes in glomerular pathobiology
Asanuma, K., & Mundel, P. (2003) · Clinical and Experimental Nephrology · doi:10.1007/s10157-003-0259-6 · Cited by 262
Zhang, S. X., Wang, J. J., Gao, G., Parke, K., & Ma, J.-X. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02008 · Cited by 262
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z. (2002) · The FASEB Journal · doi:10.1096/fj.02-0030fje · Cited by 258
Self-citationSUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 239
Kowluru, R. A., & Odenbach, S. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3233 · Cited by 227
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 226
AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction
Fukami, K., Ueda, S., Yamagishi, S.-I., Kato, S., Inagaki, Y., Takeuchi, M., Motomiya, Y., Bucala, R., Iida, S., Tamaki, K., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66004.x · Cited by 218
Self-citationYamagishi, S.-I., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., Yoshida, Y., Matsuura, T., Narama, I., Motomiya, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602110200 · Cited by 217
Self-citationYamagishi, S.-I., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6312 · Cited by 209
Self-citationVascular Endothelial Growth Factor Plays a Role in Hyperpermeability of Diabetic Retinal Vessels
Murata, T., Ishibashi, T., Khalil, A., Hata, Y., Yoshikawa, H., & Inomata, H. (1995) · Ophthalmic Research · doi:10.1159/000267567 · Cited by 199
Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., & Yamamoto, H. (1998) · Diabetologia · doi:10.1007/s001250051089 · Cited by 194
Self-citationReiniger, N., Lau, K., McCalla, D., Eby, B., Cheng, B., Lu, Y., Qu, W., Quadri, N., Ananthakrishnan, R., Furmansky, M., et al. (2010) · Diabetes · doi:10.2337/db09-1766 · Cited by 177
Ishibashi, Y., Matsui, T., Takeuchi, M., & Yamagishi, S.-I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.075 · Cited by 173
Self-citationThe Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Moore, T. C. B., Moore, J. E., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Campbell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B., et al. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1063 · Cited by 172
Yamagishi, S.-I., Inagaki, Y., Amano, S., Okamoto, T., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00940-3 · Cited by 171
Self-citationFUNATSU, H., YAMASHITA, H., NAKAMURA, S., MIMURA, T., EGUCHI, S., NOMA, H., & HORI, S. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.030 · Cited by 168
Yamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., & Takeuchi, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00752.x · Cited by 152
Self-citationMolecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention
Yamagishi, S., Fukami, K., Ueda, S., & Okuda, S. (2007) · Current Drug Targets · doi:10.2174/138945007781386884 · Cited by 151
Self-citationVascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Kim, N. H., Oh, J. H., Seo, J. A., Lee, K. W., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Kang, Y. S., Han, S. Y., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00067.x · Cited by 147
Bucala, R., Mitchell, R., Arnold, K. S., Innerarity, T. L., Vlassara, H., & Cerami, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10828 · Cited by 147
Yamagishi, S., Nakamura, K., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.983 · Cited by 141
Self-citationThiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Marx, N., Walcher, D., Ivanova, N., Rautzenberg, K., Jung, A., Friedl, R., Hombach, V., Caterina, R. D., Basta, G., Wautier, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2662 · Cited by 136
Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney
Thomas, M. C., Tikellis, C., Burns, W. M., Bialkowski, K., Cao, Z., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Cooper, M. E., & Forbes, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010013 · Cited by 136
On the Pathogenesis of Diabetic Retinopathy
Frank, R. N. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32253-x · Cited by 133
Takeuchi, M., & Yamagishi, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0974 · Cited by 129
Self-citationLiu, H., Ren, J.-G., Cooper, W. L., Hawkins, C. E., Cowan, M., & Tong, P. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308342101 · Cited by 128
HO, T., Chen, S., Yang, Y., Liao, C., CHENG, H., & TSAO, Y. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.032 · Cited by 128
Focus on Molecules: Pigment epithelium-derived factor (PEDF)
Becerra, S. P. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.016 · Cited by 119
Inagaki, Y., Yamagishi, S., Okamoto, T., Takeuchi, M., & Amano, S. (2003) · Diabetologia · doi:10.1007/s00125-002-1013-4 · Cited by 119
Self-citationPEDF: a potential molecular therapeutic target with multiple anti-cancer activities
Ek, E. T., Dass, C. R., & Choong, P. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.08.009 · Cited by 115
Yoshida, T., Yamagishi, S., Nakamura, K., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0437-7 · Cited by 108
Self-citationAdvanced Glycation Endproducts Accelerate Calcification in Microvascular Pericytes
Yamagishi, S., Fujimori, H., Yonekura, H., Tanaka, N., & Yamamoto, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0625 · Cited by 107
Self-citationYamagishi, S., Nakamura, K., Matsui, T., Noda, Y., & Imaizumi, T. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597416 · Cited by 104
Self-citationChen, Q., Dong, L., Wang, L., Kang, L., & Xu, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.040 · Cited by 103
Chang, P.-C., Chen, T.-H., Chang, C.-J., Hou, C.-C., Chan, P., & Lee, H.-M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00602.x · Cited by 101
Fan, Q., Liao, J., Kobayashi, M., Yamashita, M., Gu, L., Gohda, T., Suzuki, Y., Wang, L. N., Horikoshi, S., & Tomino, Y. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh499 · Cited by 95
Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Mitamura, Y., Takeuchi, S., Matsuda, A., Tagawa, Y., Mizue, Y., & Nishihira, J. (2001) · Ophthalmologica · doi:10.1159/000050900 · Cited by 90
Chiarelli, F., Cipollone, F., Mohn, A., Marini, M., Iezzi, A., Fazia, M. L., Tumini, S., Cesare, D. D., Pomilio, M., Pierdomenico, S. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1829 · Cited by 90
Salutary Effect of Pigment Epithelium–Derived Factor in Diabetic Nephropathy
Wang, J. J., Zhang, S. X., Mott, R., Knapp, R. R., Cao, W., Lau, K., & Ma, J. (2006) · Diabetes · doi:10.2337/db05-1448 · Cited by 87
Wang, J. J., Zhang, S. X., Lu, K., Chen, Y., Mott, R., Sato, S., & Ma, J. (2005) · Diabetes · doi:10.2337/diabetes.54.1.243 · Cited by 86
Shaw, S., Schmidt, A. M., Banes, A. K., Wang, X., Stern, D. M., & Marrero, M. B. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2381 · Cited by 83
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1992) · Proceedings of the National Academy of Sciences · Cited by 82
Tang, S. C. W., Leung, J. C. K., Chan, L. Y. Y., Tsang, A. W. L., & Lai, K. N. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101113 · Cited by 79
Role of Advanced Glycation End Products (AGEs) in Thrombogenic Abnormalities in Diabetes
Takenaka, K., Yamagishi, S., Matsui, T., Nakamura, K., & Imaizumi, T. (2006) · Current Neurovascular Research · doi:10.2174/156720206775541804 · Cited by 77
Self-citationYamagishi, S., Takeuchi, M., Matsui, T., Nakamura, K., Imaizumi, T., & Inoue, H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.058 · Cited by 76
Self-citationYamagishi, S., Matsui, T., Nakamura, K., Takeuchi, M., & Imaizumi, T. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.04.002 · Cited by 75
Self-citationHoenig, M., Bianchi, C. F., Rosenzweig, A., & Sellke, F. W. (2008) · Current Molecular Medicine · doi:10.2174/156652408786733685 · Cited by 74
Schrijvers, B. F., Flyvbjerg, A., Tilton, R. G., Lameire, N. H., & Vriese, A. S. D. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi217 · Cited by 65
Matsui, T., Yamagishi, S., Takeuchi, M., Ueda, S., Fukami, K., & Okuda, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.004 · Cited by 64
Self-citationBhatwadekar, A. D., Glenn, J. V., Li, G., Curtis, T. M., Gardiner, T. A., & Stitt, A. W. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1015 · Cited by 62
Yamagishi, S., Nakamura, K., & Matsui, T. (2007) · Current Molecular Medicine · doi:10.2174/156652407781387073 · Cited by 62
Self-citationYamagishi, S., Matsui, T., Nakamura, K., Inoue, H., Takeuchi, M., Ueda, S., Okuda, S., & Imaizumi, T. (2007) · Ophthalmic Research · doi:10.1159/000111152 · Cited by 60
Self-citationŠebeková, K., Gazdíková, K., Syrova, D., et al. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001541 · Cited by 60
Yamagishi, S., Matsui, T., Nakamura, K., Inoue, H., Takeuchi, M., Ueda, S., Fukami, K., Okuda, S., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.001 · Cited by 59
Self-citationScheubel, R. J., Kahrstedt, S., WEBER, H., Holtz, J., Friedrich, I., Börgermann, J., Silber, R., & Simm, A. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.002 · Cited by 55
Maeda, S., Matsui, T., Takeuchi, M., Yoshida, Y., Yamakawa, R., Fukami, K., & Yamagishi, S. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.11.008 · Cited by 55
Self-citationIncreased Aggregation of Human Platelets Produced by Advanced Glycation End Productsin Vitro
Hangaishi, M., Taguchi, J., Miyata, T., Ikari, Y., Togo, M., Hashimoto, Y., Watanabe, T., Kimura, S., Kurokawa, K., & Ohno, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8945 · Cited by 54
Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Takeuchi, M., Kikuchi, S., Ohno, S., & Yoshimura, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02218-0 · Cited by 50
Self-citationUeno, H., Koyama, H., Fukumoto, S., Tanaka, S., Shoji, T., Shoji, T., Emoto, M., Tahara, H., Inaba, M., Kakiya, R., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.001 · Cited by 48
Yamagishi, S., Amano, S., Inagaki, Y., Okamoto, T., Takeuchi, M., & Makita, Z. (2002) · Molecular Medicine · doi:10.1007/bf03402164 · Cited by 45
Self-citationYamagishi, S., Matsui, T., Nakamura, K., Takeuchi, M., & Inoue, H. (2008) · Protein and Peptide Letters · doi:10.2174/092986608785203746 · Cited by 44
Self-citationSaisho, Y., Komiya, N., & Hirose, H. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.015 · Cited by 44
Ma, L., Gao, H., Li, B., Ma, Y., You, B.-A., & Zhang, F.-L. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31803c5616 · Cited by 42
Chen, J., Huang, L. J., Song, M., Yu, S., Gao, P., & Jing, J. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31819b5438 · Cited by 42
Yamagishi, S., Matsui, T., Nakamura, K., Ueda, S., Noda, Y., & Imaizumi, T. (2008) · Current Drug Targets · doi:10.2174/138945008786786154 · Cited by 40
Self-citationOttonello, L. C., Morone, M. P., Dapino, P., & Dallegri, F. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05348.x · Cited by 39
Ho, T., Yang, Y., Chen, S., Kuo, P., Sytwu, H., Cheng, H.-C., & Tsao, Y. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.08.004 · Cited by 31
Angiogenesis and Metastasis Inhibitors for the Treatment of Malignant Melanoma
Abe, R., Fujita, Y., & Yamagishi, S. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707780859440 · Cited by 27
Self-citationYoshida, T., Yamagishi, S., Matsui, T., Nakamura, K., Ueno, T., Takeuchi, M., & Sata, M. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600204 · Cited by 25
Self-citationZoltowska, M., DELVIN, E. E., Ziv, E., et al. (2004) · Lipids · doi:10.1007/s11745-004-1205-7 · Cited by 23
Cited by
Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies
Rani, V., Deep, G., Singh, R. K., Palle, K., & Yadav, U. C. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.002 · Cited by 1,139
Oxidative Stress in Aging Human Skin
Rinnerthaler, M., Bischof, J., Streubel, M., Trost, A., & Richter, K. (2015) · Biomolecules · doi:10.3390/biom5020545 · Cited by 1,053
Oxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
“speculated to be the primary mechanism by which AGEs promotes OS [77].”
BackgroundVistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., & Aldini, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.815348 · Cited by 823
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Metadata
- Authors
- Yamagishi, S.-I., Maeda, S., Matsui, T., Ueda, S., Fukami, K., & Okuda, S.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 1820
- Issue
- 5
- Pages
- 663-671
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W2118332826
- Cited by
- 294
- References
- 111
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.